Brief: Ethris And Lonza Collaborate To Develop Spray-Dried Mrna Vaccines
07/04/2025 11:04
April 7 (Reuters) - LONZA GROUP AG LONN.S: ETHRIS AND LONZA COLLABORATE TO DEVELOP SPRAY-DRIED MRNA VACCINES FOR RESPIRATORY DISEASE PREVENTION Source text: ID:nBw5P29fLa Further company coverage: LONN.S (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600; ))
Recent news on Lonza AG
See all newsLonza buys 5 sites from Germany's Merck to more than double US footprint (updated)
Brief: Merck KGaA Confirms Divestment Of CDMO Business To Lonza
Lonza agrees to buy five US sites from Merck KGaA
Corrected: TABLE-Swiss trade surplus at CHF 4.35 bln in August (Sept. 17)
Table: Swiss trade surplus at CHF 1.31 bln in September